BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Life Sciences British Columbia - ECPv6.15.18//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Life Sciences British Columbia
X-ORIGINAL-URL:https://lifesciencesbc.ca
X-WR-CALDESC:Events for Life Sciences British Columbia
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/Vancouver
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20170312T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20171105T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20180311T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20181104T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20190310T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20191103T090000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20180306
DTEND;VALUE=DATE:20180307
DTSTAMP:20260408T160704
CREATED:20210407T222900Z
LAST-MODIFIED:20210914T162922Z
UID:24314-1520294400-1520380799@lifesciencesbc.ca
SUMMARY:LifeSciences BC Blakes Breakfast Speaking Event
DESCRIPTION:This Breakfast Speaking Series is proudly presented by: \n \nOn Tuesday\, March 6\, 2018\, LifeSciences BC held a Blakes Breakfast Speaking Event. \nThe Blakes Breakfast Speaking Series is our longest-standing event series and one of our most popular. Held four times a year\, these breakfasts include presentations by local\, national and multinational life science companies and typically attract a cross-section of approximately 40 of our life sciences community members. The Breakfast Speaking Series is proudly presented by Blake\, Cassels & Graydon LLP. \nKeynote speaker: \nDr. Arpita Maiti\, Senior Director\, External Science & Innovation (ES&I)\, Inflammation & Immunology and Microbiome at Pfizer Boston \nSpeakers: \nDr. Rob Fraser\, CEO at Molecular You \nMalcolm Kendall\, CEO at Microbiome Insights \nSacha Mann\, President at BioSys
URL:https://lifesciencesbc.ca/event/lifesciences-bc-blakes-breakfast-speaking-event-5/
CATEGORIES:2018
ATTACH;FMTTYPE=image/jpeg:https://lifesciencesbc.ca/wp-content/uploads/2021/03/fallnetworkingevent-1.jpeg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20180222
DTEND;VALUE=DATE:20180223
DTSTAMP:20260408T160704
CREATED:20210407T223052Z
LAST-MODIFIED:20210903T213559Z
UID:24316-1519257600-1519343999@lifesciencesbc.ca
SUMMARY:LifeSciences BC McCarthy Spotlight Speaking Series
DESCRIPTION:This Spotlight Speaking Series was proudly presented by: \n \nOn Thursday\, February 22\, 2018\, LifeSciences BC held the spring McCarthy Spotlight Speaking Event. \nEvent topic: Strategic Partnerships\, Accelerating Innovation \nOur McCarthy Spotlight Speaking Series is one of our longest-standing event series – and one in which our attendees see the most value. Held twice a year\, these events start with presentations on specific topics by local representatives of LifeSciences BC members. Typically\, the event is attended by a cross-section of approximately 40 of our life sciences community members representing mainly industry\, NPOs\, and Government. \nIn the past\, the series has featured topics focusing on attracting and keeping good talent\, technology and licensing\, M&A and Capital Markets\, to name a few. \nSpeakers:  \nPaul Kang\, Chief Scientific Officer at Innovative Targeting Solutions \nTamer Mohamed\, CEO at Aspect Biosystems \nDavid Poon\, Executive Director of External R&D and Alliances at Zymeworks
URL:https://lifesciencesbc.ca/event/lifesciences-bc-mccarthy-spotlight-speaking-series/
CATEGORIES:2018
ATTACH;FMTTYPE=image/jpeg:https://lifesciencesbc.ca/wp-content/uploads/2021/04/mccarthy2018.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20180117
DTEND;VALUE=DATE:20180119
DTSTAMP:20260408T160704
CREATED:20210407T223304Z
LAST-MODIFIED:20211108T222753Z
UID:24319-1516147200-1516319999@lifesciencesbc.ca
SUMMARY:2018 Access to Innovation
DESCRIPTION:On Wednesday\, January 17 and Thursday\, January 18\, 2018\, LifeSciences BC held the 2018 Access to Innovation event. \n2018 ACCESS TO INNOVATION\nThank you to our event supporters! \nBDC Capital joined as co-presenter this year\, following on the success of the first-ever Canadian Corporate Innovation Summit.\nSpeaker Bios: \n2018 Access to Innovation Speakers – Day 1\n2018 Access to Innovation Speakers – Day 2\nDeloitte Conference Materials:\nDeloitte-uk-life-sciences-health-care-predictions-2022 Western Canada Edition \n \nConfirmed Speakers:\n\n\nOhad Arazi: Vice President & General Manager\, TELUS Health Living Labs\nDr. Cedric Bisson: Partner\, Teralys Capital\nEla Borenstein\, Program Director\, BDC Capital\n\n\nVern Brownell: CEO\, D-Wave Systems\nDr. Pieter Cullis\, Director\, NanoMedicines Research Group; Professor\, Department of Biochemistry and Molecular Biology\n\nDr. Elai Davicioni: President & Chief Scientific Officer\, GenomeDX Biosciences\nKarimah Es Sabar: CEO & Partner\, Quark Venture Inc and the Director of the Global Health Sciences Fund\nPamela Fralick: President\, Innovative Medicines Canada\n\nDr. Mark Gelfer: Chairman\, GenXys Health Care Systems Inc.\n\nDr. Tom Hawes: Managing Director\, BlueCross BlueShield Venture Fund\nPeter Jones: Industry Lead – Healthcare\, Microsoft Canada\nDr. Steven Jones\, Associate Director and Head\, Bioinformatics\, Genome Sciences Centre\, Vancouver\nDr. Dermot Kelleher\, Dean\, Faculty of Medicine\, University of British Columbia\nErik Kiss: CEO\, Imaging Reality\nDion Madsen\, Senior Managing Partner\, Healthcare Fund\, BDC Venture Capital\nDr. Steve Mathias: Clinical Assistant Professor\, UBC\nDavid McGovern: Associate Deputy Minister\, Innovation\, Science and Economic Development Canada\nDr. Joby McKenzie: Senior Vice President Business Development\, LifeLabs\nDr. Peter McWilliams: Managing Director\, Sanderling Ventures\nFazil Mihlar: Deputy Minister\, Ministry of Jobs\, Trade & Technology\, Government of British Columbia\nDr. Gail Murphy\, Vice-President Research & Innovation\, UBC\nSue Paish: Healthcare Leader\nDr. Jeff Pike: Clinical Transformation Lead\, Providence Health Care\nDr. Simon Pimstone: President & CEO\, Xenon Pharmaceuticals\, Founder\, SAVE BC\nDr. Mohammed Qadir: President & Chief Scientific Officer\, Fusion Genomics Corporation\nDr. Alan Rabinowitz: Co-Founder\, Chief Medical Officer & a Director PHEMI Health Systems\nDr. Rachael Ritchie: Vice President\, Strategy and Partnerships\, The Centre for Drug Research & Development\nRobert Scully: Director\, Manulife Capital Ventures\nMike Standing\, Leader Life Sciences and Health Care EMEA Region\, Deloitte\nDr. Lesley Stolz: Head\, JLABS California\nBill Tam: Interim Co-Chair\, Canada’s Digital Technology Supercluster\nKaren Wichuk: Executive Lead\, Health City Edmonton\nDr. Peter Zandstra\, Director\, School of Biomedical Engineering\, UBC\, Director\, Michael Smith Laboratories\, UBC\n\nDr. Steven Xanthoudakis: Chief Business Development Officer\, CQDM Quebec Consortium for Drug Discovery\n\n\nConference Partner: \nLuncheon Sponsors: GSK \nPresenting Afternoon Sponsor: \nSession Sponsors:  \nReception Sponsor: \nBreakfast & Morning Refreshment Sponsor:  \nGeneral Supporter: GenomeBC
URL:https://lifesciencesbc.ca/event/2018-access-to-innovation/
CATEGORIES:2018
ATTACH;FMTTYPE=image/jpeg:https://lifesciencesbc.ca/wp-content/uploads/2021/04/accesstoinnovation2018.jpg
END:VEVENT
END:VCALENDAR